Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of IV N-acetylcysteine in Chinese Healthy Volunteers
NCT03881163Phase 1Completed
- Sponsor
- Zambon
- Start
- Nov 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of acetylcysteine, sponsored by Zambon. Primary endpoints: Peak Drug Concentration After Single Dose at Day 2, Time to Achieve Cmax After Single Dose at Day 2 and 13 more. Started Nov 2019; status: completed.
02
Drugs
acetylcysteine
Beyond the preview
Go deeper on NCT03881163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03881163.